Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 3145 of 6351
-
Parkinson's patients try At-Home brain zaps to improve walking
Symptom relief CompletedThe purpose of this study is to investigate the efficacy and safety of self-administered transcranial direct current stimulation to improve the single- and dual-task gait in patients with Parkinson's disease.
Sponsor: Seoul National University Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:25 UTC
-
Brain scans reveal how new combo drug curbs appetite
Symptom relief CompletedPart A: The study will look at participants appetite and energy intake and also look at the mechanisms of brain associated with appetite and food intake. Participants will not get any medicine and will be in a group that will be compared to another group receiving a weight-loss m…
Phase 1 • Sponsor: Novo Nordisk A/S • Aim: Symptom relief
Last updated Jun 27, 2026 08:09 UTC
-
New study aims to stop superbugs before they start
Knowledge-focused OngoingIn 2022, in collaboration between the Botswana Ministry of Health (MOH), the U.S. Centers for Disease Control \& Prevention, and the Botswana-UPenn Partnership (BUP), a program was launched called, "Surveillance of Healthcare-associated infections \& Antimicrobial Resista…
Sponsor: University of Pennsylvania • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:58 UTC
-
Heart surgery patients may get new shield against dangerous rhythm
Prevention Recruiting nowThe purpose of this study is to evaluate the combination of CardiaMend, with the addition of amiodarone in the prevention of postoperative atrial fibrillation (POAF) in patients undergoing cardiac arterial bypass grafting (CABG) or valve surgery.
Early phase 1 • Sponsor: University of Chicago • Aim: Prevention
Last updated Jun 27, 2026 09:09 UTC
-
Vitamin e gel could stop Dupuytren's before fingers curl
Prevention Recruiting nowDupuytren disease (DD) is a common hand disorder with disabling finger contractures that may require surgery to restore function. In the early stages of the disease, the nodules (Tubiana stage 0) are usually painless, but a reason for concern to many patients. Not rarely, lifesty…
Phase 2 • Sponsor: Universitaire Ziekenhuizen KU Leuven • Aim: Prevention
Last updated Jun 27, 2026 12:32 UTC
-
New hope for heart patients: drugs target hidden inflammation from blood mutations
Disease control CompletedThis Phase 2a clinical trial evaluated the effectiveness, safety, and tolerability of increasing dose strengths of an oral daily medication, DFV890, administered for 12 weeks, or a single s.c. dose of MAS825, to reduce key markers of inflammation related to CVD risk, such as IL-6…
Phase 2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Virtual reality could cure stage fright in just one session
Symptom relief Stopped earlyThis study aims to examine the efficacy of exposure using virtual reality (VR) for public speaking anxiety in young adults in two treatment arms: a one-session VR exposure therapy with a 4-week online transition intervention versus a three-session VR exposure therapy with a 4-wee…
Sponsor: Vilnius University • Aim: Symptom relief
Last updated Jul 19, 2026 00:00 UTC
-
Magic mushroom compound probes brain in FND patients
Knowledge-focused CompletedThe goal of this study is to learn about the brain network response in people who have functional neurological disorder who are administered with a single dose of the psychedelic psilocybin with therapeutic support. The main question it aims to answer is: Can the default mode n…
Sponsor: King's College London • Aim: Knowledge-focused
Last updated Jul 25, 2026 00:00 UTC
-
Can a Plant-Based compound boost good cholesterol in High-Risk patients?
Disease control Recruiting nowThe Investigators will test the hypothesis that 2-HOBA will reduce modification of HDL and LDL and improve HDL function in humans with heterozygous FH. The Investigators plan to first study subjects with Familial Hypercholesterolemia (FH), treating them with 750 mg of 2-HOBA or p…
Phase 2 • Sponsor: Vanderbilt University Medical Center • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
Can a diabetes drug help hearts recover after valve surgery?
Disease control CompletedThe study is a randomized, placebo-controlled, and double-blinded trial in patients with aortic stenosis (AS) undergoing aortic valve replacement (AVR). After AVR, patients will be randomized 1:1 to empagliflozin (SGLT2i) or placebo to investigate whether empagliflozin is superio…
Phase 4 • Sponsor: Rigshospitalet, Denmark • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Heart failure patients may finally ditch thirsty fluid rules
Knowledge-focused Recruiting nowHeart failure is the most common cause of admission to hospital and is associated with high morbidity and mortality. Treatment options consist of medical- and device treatment and self-care strategies, where fluid restriction has been one of the components in the self-care manage…
Sponsor: Region Stockholm • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:08 UTC
-
Could a probiotic boost fertility? new study investigates
Disease control Recruiting nowIn the last decades, numerous publications have broken the old paradigm that considered the urogenital tracts as sterile, demonstrating that microorganisms present in the urogenital tract represent the 9% of the whole human microbiome. Healthy urogenital microbiome improves impla…
Sponsor: ProbiSearch SL • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Shining a light on PAD: simple home therapy could ease walking pain
Symptom relief OngoingThe LIGHT PAD Trial is a Phase II multi-centered randomized clinical trial to collect preliminary data to test whether daily far red light treatment of the lower extremities in people with PAD improves six-minute walk distance, lower extremity perfusion, and ischemia-related dama…
Sponsor: Northwestern University • Aim: Symptom relief
Last updated Jun 27, 2026 13:04 UTC
-
Could a common supplement ease jaundice? new trial investigates
Disease control CompletedInvestigating the efficacy, safety, and molecular mechanism of N-acetylcysteine supplementation in improving elevated direct bilirubin level and liver function tests in patients with hepatic and post-hepatic jaundice.
Phase 2 • Sponsor: Tanta University • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Could a gentle zap to the neck help teens with POTS?
Symptom relief CompletedThe purpose of this study is to determine if nVNS will decrease autonomic symptom intensity (COMPASS-31 and Child Functional Disability Inventory) in adolescent patients with postural orthostatic tachycardia syndrome (POTS) in comparison to standard recovery STEPS management.
Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated Jun 27, 2026 07:56 UTC
-
Could a prostate cancer drug help women with fatty liver and PCOS?
Disease control Recruiting nowNonalcoholic steatohepatitis (NASH), or fat-related liver inflammation and scarring is projected to be the leading cause of cirrhosis in the United States (U.S.) within the next few years. Women are at disproportionate risk for NASH, with approximately 15 million U.S. women affec…
Phase 1 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Spinal zap aims to get Parkinson's patients moving again
Symptom relief Recruiting nowThe purpose of this clinical trial is to assess the preliminary safety and efficacy of the ARC-IM spinal cord stimulation therapy in alleviating locomotor deficits in individuals with Parkinson's disease. The ARC-IM Therapy employs epidural electrical stimulation (EES) to modulat…
Sponsor: Ecole Polytechnique Fédérale de Lausanne • Aim: Symptom relief
Last updated Jun 27, 2026 13:03 UTC
-
New study tests smart blood pressure monitoring to protect new moms
Disease control OngoingHypertensive disorders (HD), including preeclampsia, gestational hypertension, chronic hypertension, and chronic hypertension with superimposed preeclampsia, affect around 10-20% of pregnant women in the United States and are significantly associated with maternal mortality and m…
Sponsor: University of South Carolina • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
Heart failure patients get personalized fitness coaching to keep rehab benefits
Disease control Recruiting nowFrance has one million people with heart failure (HF). Exercise intolerance, characterised by dyspnoea, is the main clinical symptom in HF patients and a key determinant of reduced quality of life. In addition to drug and surgical treatments, cardiac rehabilitation programmes hav…
Sponsor: University Hospital, Brest • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
Magnet surgery: a new way to treat obesity and diabetes?
Disease control CompletedThe purpose of this clinical research study is to evaluate the feasibility/performance, safety and initial efficacy of the GT Metabolic Solutions DI Biofragmentable Magnetic Anastomosis System (Magnet System, DI Biofragmentable and hereafter referred to as the DI Magnet System) f…
Sponsor: GT Metabolic Solutions, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC